Peckforton Pharmaceuticals Ltd, a North West, England, UK-based supplier of specialty pharmaceuticals, recently secured over £1m in funding.
Backers include management and Enterprise Ventures, YFM Equity Partners, and the Royal Bank of Scotland.
The company intends to use the funding to develop its business both nationally and internationally (mainly in the Continental Europe) and to launch new products.
Led by Paul Boulton, Managing Director, Peckforton focuses on supplying injectable drugs to hospitals. Italso offers a range of over the counter products including antacids.